Blog Archive

Αλέξανδρος Γ. Σφακιανάκης

Thursday, November 5, 2020

Subcutaneous Rapid‐Acting Insulin Analogs for Diabetic Ketoacidosis

alexandrossfakianakis shared this article with you from Inoreader

Abstract

Diabetic ketoacidosis (DKA), characterized by hyperglycemia, metabolic acidosis, and ketosis, is a serious complication of diabetes mellitus. Treatment focuses on fluid restoration, correction of hyperglycemia, and inhibition of ketogenesis. Insulin is considered a fundamental component of DKA treatment as it promotes the peripheral tissues' utilization of glucose in peripheral tissues by reducing hepatic gluconeogenesis and suppressing ketogenesis.1

View on the web

No comments:

Post a Comment